|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova
- Culegere de postere
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/12790
Title: | Retroperitoneal sarcomas (literature review) |
Authors: | Simcov, Vasile Şchiopu, Victor Vîrlan, Mariana |
Keywords: | TPR-retroperitoneal tumor;SRP-retroperitoneal sarcoma |
Issue Date: | Oct-2020 |
Publisher: | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" |
Abstract: | Introduction: Sarcomas are malignant tumors of mesenchymal origin, constituting 1-2% of all
solid tumors. Retroperitoneal sarcomas are diagnostically challenging, owing to their
diversity and morphological overlap with other tumors arising in the
retroperitoneum.
The most common histologic types of RPS are liposarcoma and leiomyosarcoma.
Retroperitoneal sarcoma is classified based on the amount of lipid inside the cells,
the mucoid lipid and the degree of cell differentiation. Dedifferentiated
liposarcoma commonly develops in the retroperitoneum, limbs, testis, and
spermatic cord. Retro peritoneal sarcoma typically produces few symptoms until
they are large enough to compress or invade surrounding structures. Most tumors
are already large and locally advanced at the time they are first detected. Here, we
reported a case that came to medical attention as an incidentally discovered large
abdominal mass in an asymptomatic or minimally symptomatic, later the mass was
successfully removed and free from symptoms. An accurate diagnosis is necessary
for correct management and prognostication. Herein, we provide an update on the
diagnostic approach to retroperitoneal sarcomas and review their key histologic
findings and differential diagnoses. Heir prognosis is reserved with a 5-year survival rate
Purpose: of 36-58%, and the recurrence rate being 50-60%. The basic treatment for TRP is surgery. The assessment of clinical and paraclinical particularities of retroperitoneal
sarcomas, as well as the methods of treatment and its prognosis.
Material and methods: Collected data from scientific specialty literature, that were found in
Google Scholar Search, and from published studies on PubMed, Scopus, International
practice clinic guidlines. The including criteria was the articles that contained the topic of
“Retroperitoneal tumors”.
Results: Were analyzed 38 articles in the period of 2019-2020 that contained the topic of
“Retroperitoneal sarcomas”. SRP were localized in 76% of patients in the retroperitoneal
perirenal space. The most frequent histological type was liposarcoma,(Fig. 3-B,C) and
leiomyosarcoma was found only in 5-10% of cases (Fig.1D, Fig. 2A). The CT scan has a
rate of diagnostic accuracy of 97% in the case of TRP (Fig. 1, 2-A,B,C). Usually
intraoperative the sarcoma is seen with an irregular contour, being of a high density and
affecting the surrounding tissue and neighbor organs. The recurrence rate after
combined surgical treatment and chemotherapy or radiotherapy is usually of 14%.
Conclusions: Liposarcoma and leiomyosarcoma found only in 5-10% of cases. The CT scan
is the gold standard of diagnostics, the 5-year survival rate is of 36-58%, found usually after
a surgical, chemotherapy or radiotherapy treatment, with a relapse rate of 50-60%. Radical
tumor excision, which is one of the recommended treatments for TPR consists of
radical tumor excision and removes as much of the wider normal tissue margin as
possible. High-dose radiotherapy might prevent local recurrence and extend
survival. The efficacy of neoadjuvant therapy and adjuvant chemotherapy has not
yet been determined. |
URI: | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii http://repository.usmf.md/handle/20.500.12710/12790 |
Appears in Collections: | Culegere de postere
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|